副交感活性受损与肺动脉高压右室功能障碍及肺血管重构的关系
该研究探讨肺动脉高压(PAH)患者副交感活性与右心室(RV)功能的关系,并在实验性肺高血压(PH)中评估吡啶斯的明(PYR)的疗效。结果显示PAH患者RV射血分数降低与心率恢复减少相关,PYR可改善PH大鼠生存、RV功能及肺血管重构。
要点
- PAH患者RV射血分数<41%者心率恢复显著降低,提示副交感活性受损与RV功能障碍相关。
- PAH患者RV中α-7烟碱型乙酰胆碱受体表达增加且乙酰胆碱酯酶活性降低。
- PYR在实验性PH中改善生存、RV功能及肺血管重构,并降低炎症。
核心结论
- PAH患者RV功能障碍与全身副交感活性降低相关,且RV胆碱能系统存在适应不良。
- PYR增强副交感活性可改善实验性PH的生存、RV功能和肺血管重构。
研究设计与样本
- 临床部分:112例PAH患者评估运动后心率恢复与RV射血分数,另取11例PAH患者RV和7例肺组织对比对照组。
- 实验部分:SU5416注射联合4周缺氧诱导雄性大鼠PH,第6周随机分为溶媒组或PYR组(40 mg/kg/天),每组12只。
主要发现
- PAH患者RV射血分数<41%者运动后心率恢复显著低于RV射血分数较高者。
- PAH患者RV中α-7烟碱型乙酰胆碱受体表达增加、乙酰胆碱酯酶活性降低,毒蕈碱型乙酰胆碱2型受体表达无差异。
- PYR组PH大鼠副交感活性和压力反射敏感性增加,生存改善,RV收缩力增加、僵硬度和肥厚减轻。
- PYR组RV纤维化、炎症及α-7烟碱型乙酰胆碱受体和毒蕈碱型乙酰胆碱2型受体表达降低。
- PYR组肺血管阻力、RV后负荷和肺血管重构减轻,伴局部和全身炎症减少。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The beneficial effects of parasympathetic stimulation have been reported in left heart failure, but whether it would be beneficial for pulmonary arterial hypertension (PAH) remains to be explored. Here, we investigated the relationship between parasympathetic activity and right ventricular (RV) function in patients with PAH, and the potential therapeutic effects of pyridostigmine (PYR), an oral drug stimulating the parasympathetic activity through acetylcholinesterase inhibition, in experimental pulmonary hypertension (PH). METHODS: Heart rate recovery after a maximal cardiopulmonary exercise test was used as a surrogate for parasympathetic activity. RV ejection fraction was assessed in 112 patients with PAH. Expression of nicotinic (α-7 nicotinic acetylcholine receptor) and muscarinic (muscarinic acetylcholine type 2 receptor) receptors, and acetylcholinesterase activity were evaluated in RV (n=11) and lungs (n=7) from patients with PAH undergoing heart/lung transplantation and compared with tissue obtained from controls. In addition, we investigated the effects of PYR (40 mg/kg per day) in experimental PH. PH was induced in male rats by SU5416 (25 mg/kg subcutaneously) injection followed by 4 weeks of hypoxia. In a subgroup, sympathetic/parasympathetic modulation was assessed by power spectral analysis. At week 6, PH status was confirmed by echocardiography, and rats were randomly assigned to vehicle or treatment (both n=12). At the end of the study, echocardiography was repeated, with additional RV pressure-volume measurements, along with lung, RV histological, and protein analyses. RESULTS: Patients with PAH with lower RV ejection fraction (<41%) had a significantly reduced heart rate recovery in comparison with patients with higher RV ejection fraction. In PAH RV samples, α-7 nicotinic acetylcholine receptor was increased and acetylcholinesterase activity was reduced versus controls. No difference in muscarinic acetylcholine type 2 receptor expression was observed. Chronic PYR treatment in PH rats normalized the cardiovascular autonomic function, demonstrated by an increase in parasympathetic activity and baroreflex sensitivity. PYR improved survival, increased RV contractility, and reduced RV stiffness, RV hypertrophy, RV fibrosis, RV inflammation, and RV α-7 nicotinic acetylcholine receptor and muscarinic acetylcholine type 2 receptor expression, as well. Furthermore, PYR reduced pulmonary vascular resistance, RV afterload, and pulmonary vascular remodeling, which was associated with reduced local and systemic inflammation. CONCLUSIONS: RV dysfunction is associated with reduced systemic parasympathetic activity in patients with PAH, with an inadequate adaptive response of the cholinergic system in the RV. Enhancing parasympathetic activity by PYR improved survival, RV function, and pulmonary vascular remodeling in experimental PH.
引用
- da Silva Gonçalves Bós D, Van Der Bruggen CEE, Kurakula K, et al. Contribution of Impaired Parasympathetic Activity to Right Ventricular Dysfunction and Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension. Circulation. 2017. PMID: 29167228. doi:10.1161/CIRCULATIONAHA.117.027451
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。